Willow Biosciences Inc T.WLLW

Alternate Symbol(s): CANSF

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.

TSX:WLLW - Post by User

Willow Biosciences Inc

Bullboard Posts

Post by Edp007on Sep 01, 2016 4:53pm

135 Views

Post# 25200959

Makena Resources agreement for Bachman Lithium

2016-09-01 16:24 ET - Property Agreement

The TSX Venture Exchange has accepted for filing a share purchase agreement dated Aug. 24, 2016, between Makena Resources Inc. and Graeme Sewell, MGK Consulting (Jason Gigliotti) and Munir Ali, whereby the company may acquire 100 per cent of the shares of Bachman Lithium Corp. The sole asset of Bachman Lithium is a 100-per-cent interest in the Mad Lake property (80 claims, 4,478.2 hectares) located in the Abitibi area of Quebec. Consideration is 13.5 million shares, with 4.5 million shares to each of the vendors.

Bullboard Posts

Sirios Resource discovers visible gold in Quebec